BARDA continues to partner with Moderna for the first Phase 3 clinical trial of a COVID-19 vaccine to start in the United States

MedicalCountermeasures.gov

With Support from BARDA and NIH, First Phase 3 Clincial Trail of a COVID-19 Vaccine Begins in the United States

Read Release